2024 annual financial data
Lakewood-Amedex Biotherapeutics 2024 Operating margin
Lakewood-Amedex Biotherapeutics 2024 operating margin with verified reported va…
Direct answer
Operating margin was Not calculable.
Operating income was -4,026,820 USD and net income was -4,855,405 USD.
Operating cash flow was -5,723,322 USD.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,026,820 USD
- Net income
- -4,855,405 USD
- Operating cash flow
- -5,723,322 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Lakewood-Amedex Biotherapeutics financial years